CSS
NAGE

Cubist Systematic Strategies’s Niagen Bioscience NAGE Stock Holding History

Cubist Systematic Strategies’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-63,105
Closed -$909K – 3685
2025
Q2 		$909K Buy
+63,105
New +$623K ﹤0.01% 1991
2025
Q1 		– Sell
-310,369
Closed -$1.65M – 3657
2024
Q4 		$1.65M Buy
+310,369
New +$1.7M 0.01% 1492
2024
Q2 		– Sell
-9,001
Closed -$31.3K – 4211
2024
Q1 		$31.3K Buy
+9,001
New +$16.7K ﹤0.01% 3436
2023
Q1 		– Sell
-11,987
Closed -$20.1K – 4528
2022
Q4 		$20.1K Buy
+11,987
New +$19K ﹤0.01% 3993
2022
Q3 		– Sell
-63,286
Closed -$106K – 4792
2022
Q2 		$106K Buy
63,286
+37,163
+142% +$72.7K ﹤0.01% 3960
2022
Q1 		$64K Buy
+26,123
New +$71.4K ﹤0.01% 3335
2021
Q3 		– Sell
-56,453
Closed -$557K – 3220
2021
Q2 		$557K Buy
56,453
+26,199
+87% +$228K 0.01% 1938
2021
Q1 		$283K Sell
30,254
-1,433
-5% -$11.4K ﹤0.01% 2291
2020
Q4 		$152K Buy
31,687
+5,521
+21% +$26.9K ﹤0.01% 2334
2020
Q3 		$105K Buy
26,166
+4,903
+23% +$23.7K ﹤0.01% 2280
2020
Q2 		$98K Buy
+21,263
New +$95.2K ﹤0.01% 2198

Other funds holding NAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cubist Systematic Strategies's NAGE Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Niagen Bioscience (NAGE) in Q3 2025, closing a stake of 63,105 shares — an estimated $909K sold.

Cubist Systematic Strategies first reported a position in NAGE in Q2 2020 and held it in 11 quarters. The position peaked at $1.65M in Q4 2024. 162 funds tracked by Wall St. Rank hold NAGE as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Niagen Bioscience position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 63,105 Niagen Bioscience shares in Q3 2025, an estimated $909K.
  • Cubist Systematic Strategies first reported a position in Niagen Bioscience in Q2 2020 and held it in 11 quarters.
  • Cubist Systematic Strategies's Niagen Bioscience position peaked at $1.65M in Q4 2024.
  • 162 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.